Administration of recombinant TFF3 to TFF3-/- mice significantly reduced the fraction of cerebral infarcts and mitigated the loss of the injured cerebral hemisphere (Figure 7A, 7C). The gene discussed is TFF3; the disease is cerebral infarction.